Feedback Share Discussion Threads

[ged5] 04/7/2022 13:21

Nice one LR2. Just need the contracts to back up the spiel.

Two views when I looked, so that's me and you. I liked it!

[lr2] 04/7/2022 12:55

Bleepa for Radiology.

Bringing medical imaging to the heart of clinical conversations. Find out how Bleepa is providing a quicker, flexible service for radiologists to communicate with clinical teams.

[lr2] 01/7/2022 14:34

News next week? People paying outside the quote for 1 million plus.

[lr2] 28/6/2022 13:11

"Feedback Medical uses Zoho Flow to automate key workflows and eliminate manual work" Adam Kentrop, Senior Systems Engineer, Feedback Medical

[ged5] 27/6/2022 13:54

Thanks LR2, post 10019.

Not really sure what the other links were showing about Bleepa.

So average time for a referral was improved by 56% and to complete a referral by 49%

Sounds good to me but does anyone know how that compares to any other referral system?

[digger2779] 27/6/2022 10:53

Cheers LR.

[lr2] 27/6/2022 08:40

Four more Bleepa references via a search made courtesy of Private Ryan over on the other place.

[ducatiman] 27/6/2022 04:14

Good info LR2. Thank you. Manchester and Oldham.

[lr2] 27/6/2022 01:00

Bleepa references within the below link.

P256 Improving processes and response times for gastroenterology referrals

[lr2] 22/6/2022 18:06

Thanks for that update SSB, someone else told me the same thing recently. I had a top up recently at 0.64p as I believe there will be news of more sales of Bleepa / CareLocker in the next few weeks.

I see BIRD had a better day, today. Here's hoping we both have better times ahead of us.

[sideshowbull] 22/6/2022 17:46

LR, the chart filled the gap, FYI.

Not saying I would be buying but that was a magnet.


BWTFDIK

[lr2] 20/6/2022 12:27

Bleepa has a TB screening opportunity in Wales.

Three diagnosed with TB after person dies at Welsh university campus

[digger2779] 16/6/2022 23:07

LR2 - that one works thanks. So in 5 years we will all be millionaires!!! I've just got to keep the grim reaper at bay for a bit longer than I was planning haha.

[lr2] 16/6/2022 17:33

Hi Digger,

The video appears to have a new link for some reason. Try this.

[lr2] 16/6/2022 17:19

Hi Digger,

I listened to it twice and don't recall anything out of the ordinary on it.

Hi TooDeep,

Take out the £10 mil cash and we have a company capable of producing £882k revenue from existing sources. Products of company are thus valued at around 8 times yearly revenue based on last 6 month revenue.

Assume 3-4 new UK groups on board in next 6 months (hopefully more) and TB testing program in Odisha gets the OK to go statewide then (Odisha pop 45 mil) 5% population (ultimately aiming at 20% a year) testing is 2.25 mil at £2 with scans captured on CareLocker, company gets revenue of £882k x 2 = £1.75 plus £4.5 mil. Total revenue £6.25 mil. £6.25 mil x 8 for MCAP calc = £50 mil. 1.8p a share.

The following is from the Year End Trading Update and appears to have been overlooked by many today.
I suspect that it should not be as a move into 'further sites' will soon have a very positive effect on profits.

"Feedback also made significant progress in India with its cloud TB screening pilot service going live at the Evangelical Hospital Khariar in Odisha in March, following which over 250 patients have now gone through the workflow. This pilot is being used to generate evidence which will enable the Company to expand into further sites and pursue opportunities to commercialise the offering."

Definitely forward looking of me with a bunch of assumptions that need to materialise but, in my eyes, not impossible to obtain. I guess we will know more in six months time.

Edit: original figure of 1.6p was wrong as my original population figures for Odisha were 5 years out of date.

[digger2779] 16/6/2022 16:47

LR -16 Jun '22 - 12:42 - 10003 of 10011
0 1 0
Tom Oakley and the lovely Katie.



The video has been removed. Was it any good?

[intoodeep] 16/6/2022 16:10

Thank you very much.

So would you say that 200% revenue growth is an easy target to get to say £2.5m for year to May 2023? Sounds like a definite maybe, subject to new groups coming on board?

Sill not sure how the share price would re-rate to 1.6p in the near term though to give an MCAP of some £42m or +150% from today? Surely the revenue numbers would need to be closer to say £7m p.a to get an MCAP of 5x Revenues?

£0.007 Share Price
2,667,000,000 No of Shares
£17,335,500 Mcap

£0.016 Share Price
2,667,000,000 No of Shares
£42,672,000 MCAP

[intoodeep] 16/6/2022 14:17

Guys appreciate the comments.

Annual income of £0.6m to May 2022.
Some deferred Income for next year £0.1m
Cash in bank of £10.1m
MCAP £17m

If sales were to double to say £1.2m how can the MCAP be re-rated in this market.

MCAP doesn't look low, so what am I missing?

[ged5] 16/6/2022 14:06

Thanks, will edit.

No, I'm thinking 80k sales will be included in revenues in future results.

They've talked about deferred sales in the past somewhere. Probably an RNS but I have a vague recollection of an explanation in one of the interviews.

[lr2] 16/6/2022 14:05

Sales during the current financial year - £670k.
Revenue for the current financial year - £590k
Sales for the next financial year - £80k.

That's how I see it. They take revenue in the month it is due.

[intoodeep] 16/6/2022 13:51

Understood but it's actually £590k revenues(not £509k) v £670k sales diff + £80K between sales and revenues. Are you thinking that none of the £670k sales were counted in the revenues of £590k?